CHINA RESOURCES PHARMACEUTICAL GR earnings per share and revenue

3320 earnings per share for the last semiannual are 0.12 HKD whereas the estimation was 0.23 HKD which accounts for -47.90% surprise. Company revenue for the same period amounts to 128.29 B HKD despite the estimated figure of 125.95 B HKD. Estimated earnings per share for the next semiannual are 0.41 HKD, and revenue is expected to reach 134.34 B HKD. Also watch annual changes over time to get a bigger picture of 3320 earnings per share and revenue dynamics.